Company Filing History:
Years Active: 2018
Title: Kun Su - Innovator in Cyclic Peptide Compounds
Introduction
Kun Su is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of cyclic peptide compounds. His innovative work has the potential to impact the treatment of diseases associated with histone deacetylase dysregulations.
Latest Patents
Kun Su holds a patent for a cyclic peptide compound, along with its preparation method, pharmaceutical composition, and use. The patent describes a compound with a specific structure, as indicated by general formula (I). This compound, along with its isomers, racemates, pharmaceutically acceptable salts, crystalline hydrates, solvates, or mixtures thereof, is intended for use in the preparation of medicaments aimed at preventing or treating mammalian diseases linked to histone deacetylase dysregulations.
Career Highlights
Kun Su is associated with Hangzhou Guanyu Bio-medical Co., Ltd., where he applies his expertise in medicinal chemistry. His work at the company focuses on the development of innovative pharmaceutical solutions that address critical health issues.
Collaborations
He collaborates with notable colleagues, including Sheng Jiang and Zhiyi Yao, who contribute to the research and development efforts at Hangzhou Guanyu Bio-medical Co., Ltd. Their combined expertise enhances the potential for groundbreaking advancements in the field.
Conclusion
Kun Su's contributions to the field of cyclic peptide compounds exemplify the innovative spirit of modern science. His work not only advances medicinal chemistry but also holds promise for improving health outcomes in various diseases.